OPA
MRNA icon

Old Port Advisors’s Moderna MRNA Stock Holding History

Old Port Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$937K Sell
13,386
-225
-2% -$11.6K 0.18% 124
2026
Q1 		$691K Buy
13,611
+3,215
+31% +$150K 0.16% 140
2025
Q4 		$307K Sell
10,396
-4,170
-29% -$113K 0.08% 189
2025
Q3 		$376K Sell
14,566
-1,149
-7% -$32.1K 0.09% 172
2025
Q2 		$434K Buy
15,715
+181
+1% +$4.77K 0.12% 161
2025
Q1 		$440K Buy
15,534
+2,958
+24% +$105K 0.13% 143
2024
Q4 		$523K Sell
12,576
-610
-5% -$29.2K 0.15% 137
2024
Q3 		$881K Sell
13,186
-247
-2% -$22.7K 0.24% 110
2024
Q2 		$1.6M Sell
13,433
-45
-0.3% -$5.7K 0.48% 74
2024
Q1 		$1.44M Buy
13,478
+2,317
+21% +$234K 0.44% 81
2023
Q4 		$1.11M Sell
11,161
-1,259
-10% -$106K 0.37% 89
2023
Q3 		$1.28M Buy
+12,420
New +$1.39M 0.47% 78
2023
Q1 		$2.58M Buy
16,610
+50
+0.3% +$8.25K 0.93% 33
2022
Q4 		$2.97M Buy
16,560
+280
+2% +$45.8K 1.12% 23
2022
Q3 		$2.04M Buy
16,280
+5,070
+45% +$769K 0.81% 33
2022
Q2 		$1.74M Buy
11,210
+436
+4% +$62.3K 0.67% 46
2022
Q1 		$1.9M Buy
10,774
+401
+4% +$67.5K 0.65% 49
2021
Q4 		$2.24M Buy
10,373
+642
+7% +$188K 0.76% 41
2021
Q3 		$2.94M Sell
9,731
-3
-0% -$1.11K 1.07% 24
2021
Q2 		$2.4M Sell
9,734
-187
-2% -$33.4K 0.86% 38
2021
Q1 		$1.3M Buy
9,921
+1,546
+18% +$224K 0.51% 60
2020
Q4 		$936K Buy
8,375
+2,515
+43% +$254K 0.41% 72
2020
Q3 		$415K Buy
+5,860
New +$409K 0.2% 111

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Old Port Advisors's MRNA Position: Q2 2026 in Review

Old Port Advisors reduced its Moderna (MRNA) stake by 1.7% in Q2 2026, selling an estimated $11.6K and leaving 13,386 shares worth $937K. The position accounts for 0.18% of the portfolio, ranked #124.

Old Port Advisors first reported a position in MRNA in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.97M in Q4 2022. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Old Port Advisors held 13,386 shares of Moderna worth $937K as of Q2 2026.
  • Old Port Advisors sold 225 Moderna shares in Q2 2026, an estimated $11.6K.
  • Moderna made up 0.18% of Old Port Advisors's portfolio in Q2 2026, its #124 holding.
  • Old Port Advisors first reported a position in Moderna in Q3 2020 and has held it in 23 quarters since.
  • Old Port Advisors's Moderna position peaked at $2.97M in Q4 2022.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Old Port Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.